Literature DB >> 36128483

Classic and Novel Mechanisms of Diuretic Resistance in Cardiorenal Syndrome.

Zachary L Cox1,2, Veena S Rao3, Jeffrey M Testani3.   

Abstract

Despite the incompletely understood multiple etiologies and underlying mechanisms, cardiorenal syndrome is characterized by decreased glomerular filtration and sodium avidity. The underlying level of renal sodium avidity is of primary importance in driving a congested heart failure phenotype and ultimately determining the response to diuretic therapy. Historically, mechanisms of kidney sodium avidity and resultant diuretic resistance were primarily extrapolated to cardiorenal syndrome from non-heart failure populations. Yet, the mechanisms appear to differ between these populations. Recent literature in acute decompensated heart failure has refuted several classically accepted diuretic resistance mechanisms and reshaped how we conceptualize diuretic resistance mechanisms in cardiorenal syndrome. Herein, we propose an anatomically based categorization of diuretic resistance mechanisms to establish the relative importance of specific transporters and translate findings toward therapeutic strategies. Within this categorical structure, we discuss classic and novel mechanisms of diuretic resistance.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  acute heart failure; cardiorenal syndrome; diuretic resistance; diuretics; loop diuretic; nephropharmacology

Mesh:

Substances:

Year:  2022        PMID: 36128483      PMCID: PMC9438407          DOI: 10.34067/KID.0006372021

Source DB:  PubMed          Journal:  Kidney360        ISSN: 2641-7650


  118 in total

1.  Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure.

Authors:  Veena S Rao; Noah Planavsky; Jennifer S Hanberg; Tariq Ahmad; Meredith A Brisco-Bacik; Francis P Wilson; Daniel Jacoby; Michael Chen; W H Wilson Tang; David Z I Cherney; David H Ellison; Jeffrey M Testani
Journal:  J Am Soc Nephrol       Date:  2017-07-24       Impact factor: 10.121

2.  Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.

Authors:  Wilfried Mullens; Frederik H Verbrugge; Petra Nijst; Pieter Martens; Katrien Tartaglia; Evi Theunissen; Liesbeth Bruckers; Walter Droogne; Pierre Troisfontaines; Kevin Damman; Johan Lassus; Alexandre Mebazaa; Gerasimos Filippatos; Frank Ruschitzka; Matthias Dupont
Journal:  Eur J Heart Fail       Date:  2018-09-21       Impact factor: 15.534

3.  Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure: The GALACTIC Randomized Clinical Trial.

Authors:  Nikola Kozhuharov; Assen Goudev; Dayana Flores; Micha T Maeder; Joan Walter; Samyut Shrestha; Danielle Menosi Gualandro; Mucio Tavares de Oliveira Junior; Zaid Sabti; Beat Müller; Markus Noveanu; Thenral Socrates; Ronny Ziller; Antoni Bayés-Genís; Alessandro Sionis; Patrick Simon; Eleni Michou; Samuel Gujer; Tommaso Gori; Philip Wenzel; Otmar Pfister; David Conen; Ioannis Kapos; Richard Kobza; Hans Rickli; Tobias Breidthardt; Thomas Münzel; Paul Erne; Christian Mueller; Nisha Arenja
Journal:  JAMA       Date:  2019-12-17       Impact factor: 56.272

Review 4.  Combined furosemide and human albumin treatment for diuretic-resistant edema.

Authors:  Rowland J Elwell; Ann P Spencer; George Eisele
Journal:  Ann Pharmacother       Date:  2003-05       Impact factor: 3.154

5.  Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.

Authors:  Frederik H Verbrugge; Pieter Martens; Koen Ameloot; Veerle Haemels; Joris Penders; Matthias Dupont; Wai Hong Wilson Tang; Walter Droogné; Wilfried Mullens
Journal:  Eur J Heart Fail       Date:  2019-05-09       Impact factor: 15.534

6.  Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial.

Authors:  Graziella Badin Aliti; Eneida R Rabelo; Nadine Clausell; Luís E Rohde; Andreia Biolo; Luis Beck-da-Silva
Journal:  JAMA Intern Med       Date:  2013-06-24       Impact factor: 21.873

7.  Response of the kidney to furosemide. I. Effects of salt intake and renal compensation.

Authors:  C S Wilcox; W E Mitch; R A Kelly; K Skorecki; T W Meyer; P A Friedman; P F Souney
Journal:  J Lab Clin Med       Date:  1983-09

8.  Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans.

Authors:  J J Beutler; W H Boer; H A Koomans; E J Dorhout Mees
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

9.  Adaptation of distal tubule and collecting duct to increased Na delivery. II. Na+ and K+ transport.

Authors:  B A Stanton; B Kaissling
Journal:  Am J Physiol       Date:  1988-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.